ATH 0.00% 0.5¢ alterity therapeutics limited

Shorts on low level, page-18

  1. 2,798 Posts.
    lightbulb Created with Sketch. 971
    Looks like there are no ATH presentations at the AAN meeting this year. I did not find any abstracts of ATH434, no authors such, as Finkelstein, Stefanova N, Stamler. So the positive trend there has been in the market is not related to news presented at the AAN meeting.

    This positive trend is a very short time in comparison to the 6 previous months with a downward trend from 1.30 - 1.40 level in NY. Just wondering if there are any rumors about PBT2. IMO, if there is a good reason for this small up-trend, IMO, the probable PBT2 deal is more likely to cause one, than anything with ATH434. The delay of the start of phase 2 and the extension of the treatment time from 6 months to one year was causing the downtrend, at least partially.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.